Generic placeholder image

Anti-Cancer Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5206
ISSN (Online): 1875-5992

Targeted Anti-HER2 Cancer Therapy in Elderly Women Diagnosed with Breast Cancer

Author(s): M.J. Molina-Garrido, C. Guillen-Ponce and A. Mora-Rufete

Volume 14, Issue 5, 2014

Page: [639 - 645] Pages: 7

DOI: 10.2174/18715206113139990087

Price: $65

Abstract

Trastuzumab or lapatinib treatment with chemotherapy or hormonotherapy are the gold standard treatments for human epidermal growth factor receptor 2 (HER2)-positive breast cancer (early breast cancer or metastatic breast cancer). Older patients have been largely underrepresented in clinical trials, and few data on trastuzumab or lapatinib efficacy and toxicity have been reported for this subgroup. This article has reviewed the main articles that have analyzed these items.

Keywords: Adjuvant Online, aging, anit-HER2 therapy, breast cancer, cardiotoxicity, chemotherapy, comorbidity, Comprehensive Geriatric Assessment, elderly women, histology, HER2 positive, lapatinib, St Gallen criteria, targeted therapy, trastuzumab.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy